Clinical differences between cocaine-induced psychotic disorder and psychotic symptoms in cocaine-dependent patients.
Substance-Induced Psychoses: An Updated Literature Review.
Fiorentini A, Cantù F, Crisanti C, Cereda G, Oldani L, Brambilla P.
Front Psychiatry. 2021 Dec 23;12:694863. doi: 10.3389/fpsyt.2021.694863. eCollection 2021.
Cocaine psychosis.
Baker FM.
J Natl Med Assoc. 1989 Sep;81(9):987, 990, 993-6, passim.
Drug-induced psychoses.
Hurlbut KM.
Emerg Med Clin North Am. 1991 Feb;9(1):31-52.
Cocaine hallucinations.
Siegel RK.
Am J Psychiatry. 1978 Mar;135(3):309-14. doi: 10.1176/ajp.135.3.309.
[2[[2-[[[3-(4-chlorophenyl)-8-methyl-8-azabicyclo[3,2,1]-oct-2-yl]-methyl](2-mercaptoethyl)amino]ethyl]amino]ethanethiolato(3-)-N2,N2’,S2,S2]oxo-[1R-exo-exo)])- [99mTc]-technetium.
Chopra A.
2007 Apr 24 [updated 2007 Dec 20]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.
Psychotic Symptoms Associated with the use of Dopaminergic Drugs, in Patients with Cocaine Dependence or Abuse.
Roncero C, Abad AC, Padilla-Mata A, Ros-Cucurull E, Barral C, Casas M, Grau-López L.
Curr Neuropharmacol. 2017;15(2):315-323. doi: 10.2174/1570159x14666160324144912.
Cocaine-induced psychosis.
Brady KT, Lydiard RB, Malcolm R, Ballenger JC.
J Clin Psychiatry. 1991 Dec;52(12):509-12.
Disulfiram revisited.
O'Shea B.
Hosp Med. 2000 Dec;61(12):849-51. doi: 10.12968/hosp.2000.61.12.1483.
Quetiapine for the treatment of cocaine use disorder.
Tapp A, Wood AE, Kennedy A, Sylvers P, Kilzieh N, Saxon AJ.
Drug Alcohol Depend. 2015 Apr 1;149:18-24. doi: 10.1016/j.drugalcdep.2014.12.037. Epub 2015 Jan 27.
Network analysis of psychotic manifestations among cocaine users.
Karsinti E, Labaeye M, Piani K, Fortias M, Brousse G, Bloch V, Romo L, Vorspan F.
J Psychiatr Res. 2020 Nov;130:300-305. doi: 10.1016/j.jpsychires.2020.08.020. Epub 2020 Aug 20.
